E-Pharma

E-Pharma is a specialized Contract Development and Manufacturing Organization (CDMO) based in Italy, focusing on the development and production of sophisticated oral solid dosage forms. The company is a global leader in fast-acting delivery technologies, including effervescent, orodispersible, and sublingual tablets. E-Pharma offers a comprehensive suite of services ranging from initial pre-formulation and analytical development to industrial-scale GMP manufacturing and regulatory filing support. Their state-of-the-art facilities are both EU-GMP certified and FDA-approved, allowing them to serve a diverse international clientele of pharmaceutical and nutraceutical firms. In 2022, the company was acquired by the healthcare private equity firm ArchiMed to support its expansion into new markets and enhance its technological capabilities. The company is particularly recognized for its expertise in taste-masking and the formulation of highly soluble or fast-dissolving products.